{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:47Z","timestamp":1787509187370,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/spc.0b013e3283640f74","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T08:26:58Z","timestamp":1375345618000},"page":"272-277","source":"Crossref","is-referenced-by-count":33,"title":["Vitamin D in the cancer patient"],"prefix":"10.1097","volume":"7","author":[{"given":"Kurt A.","family":"Kennel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20211004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-012-2224-2","article-title":"Health risks and benefits from calcium and vitamin D supplementation: Womens Health Initiative clinical trial and cohort study.","volume":"24","author":"Prentice","year":"2013","journal-title":"Osteoporos Int"},{"key":"R2-7-20211004","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr3390","article-title":"Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.","volume":"15","author":"Scarmo","year":"2013","journal-title":"Breast Cancer Res"},{"key":"R3-7-20211004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3945\/ajcn.2010.30009","article-title":"Vitamin D and breast cancer recurrence in the Womens Healthy Eating and Living (WHEL) Study.","volume":"93","author":"Jacobs","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R4-7-20211004","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10552-013-0158-4","article-title":"Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors.","volume":"24","author":"Villasenor","year":"2013","journal-title":"Cancer Causes Control"},{"key":"R5-7-20211004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.maturitas.2010.03.012","article-title":"Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer.","volume":"66","author":"Nogues","year":"2010","journal-title":"Maturitas"},{"key":"R6-7-20211004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(11)70389-8","article-title":"Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.","volume":"13","author":"Cheung","year":"2012","journal-title":"Lancet Oncol"},{"key":"R7-7-20211004","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s10549-012-2013-9","article-title":"Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.","volume":"133","author":"Prieto-Alhambra","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R8-7-20211004","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/annonc\/mdr017","article-title":"Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.","volume":"22","author":"Hadji","year":"2011","journal-title":"Ann Oncol"},{"key":"R9-7-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1940-6207.CAPR-10-0289","article-title":"Circulating levels of vitamin D and colon and rectal cancer: the Physicians Health Study and a meta-analysis of prospective studies.","volume":"4","author":"Lee","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"R10-7-20211004","doi-asserted-by":"crossref","first-page":"b5500","DOI":"10.1136\/bmj.b5500","article-title":"Association between prediagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study.","volume":"340","author":"Jenab","year":"2010","journal-title":"Bmj"},{"key":"R11-7-20211004","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3748\/wjg.v18.i14.1672","article-title":"Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis.","volume":"18","author":"Bai","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R12-7-20211004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/0008-5472.CAN-09-3264","article-title":"Genetic polymorphisms in vitamin D receptor VDRRXRA influence the likelihood of colon adenoma recurrence.","volume":"70","author":"Egan","year":"2010","journal-title":"Cancer Res"},{"key":"R13-7-20211004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1158\/0008-5472.CAN-10-1560","article-title":"A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.","volume":"71","author":"Ahearn","year":"2011","journal-title":"Cancer Res"},{"key":"R14-7-20211004","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2011-1309","article-title":"Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) andor calcium (RECORD trial).","volume":"97","author":"Avenell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-7-20211004","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/blood-2010-07-295683","article-title":"Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia.","volume":"117","author":"Shanafelt","year":"2011","journal-title":"Blood"},{"key":"R16-7-20211004","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1200\/JCO.2010.28.6674","article-title":"Vitamin D insufficiency and prognosis in non-Hodgkins lymphoma.","volume":"28","author":"Drake","year":"2010","journal-title":"J Clin Oncol"},{"key":"R17-7-20211004","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s10552-012-9967-0","article-title":"Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.","volume":"23","author":"Kelly","year":"2012","journal-title":"Cancer Causes Control"},{"key":"R18-7-20211004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajh.21412","article-title":"Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma.","volume":"84","author":"Ng","year":"2009","journal-title":"Am J Hematol"},{"key":"R19-7-20211004","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07214.x","article-title":"Prevalence and significance of vitamin D deficiency in multiple myeloma patients.","volume":"142","author":"Badros","year":"2008","journal-title":"Br J Haematol"},{"key":"R20-7-20211004","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1158\/0008-5472.CAN-06-1876","article-title":"A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.","volume":"66","author":"Stolzenberg-Solomon","year":"2006","journal-title":"Cancer Res"},{"key":"R21-7-20211004","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1158\/0008-5472.CAN-08-2694","article-title":"Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.","volume":"69","author":"Stolzenberg-Solomon","year":"2009","journal-title":"Cancer Res"},{"key":"R22-7-20211004","doi-asserted-by":"crossref","first-page":"281863","DOI":"10.4061\/2011\/281863","article-title":"Vitamin d, sunlight and prostate cancer risk.","volume":"2011","author":"Donkena","year":"2011","journal-title":"Adv Prev Med"},{"key":"R23-7-20211004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/aje\/kwq148","article-title":"Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.","volume":"172","author":"Kristal","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R24-7-20211004","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/djs189","article-title":"Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.","volume":"104","author":"Shui","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R25-7-20211004","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10552-012-9948-3","article-title":"Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study.","volume":"23","author":"Brandstedt","year":"2012","journal-title":"Cancer Causes Control"},{"key":"R26-7-20211004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.27327","article-title":"Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.","volume":"131","author":"Gilbert","year":"2012","journal-title":"Int J Cancer"},{"key":"R27-7-20211004","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1210\/jc.2012-1451","article-title":"Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.","volume":"97","author":"Marshall","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-7-20211004","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1210\/jc.2012-4019","article-title":"Randomized clinical trial of vitamin d3 doses on prostatic vitamin d metabolite levels and ki67 labeling in prostate cancer patients.","volume":"98","author":"Wagner","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-7-20211004","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/cncr.24973","article-title":"Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer.","volume":"116","author":"Chadha","year":"2010","journal-title":"Cancer"},{"key":"R30-7-20211004","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2010.32.8815","article-title":"Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.","volume":"29","author":"Scher","year":"2011","journal-title":"J Clin Oncol"},{"key":"R32-7-20211004","first-page":"3669","article-title":"Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.","volume":"29","author":"Nurnberg","year":"2009","journal-title":"Anticancer Res"},{"key":"R33-7-20211004","doi-asserted-by":"crossref","first-page":"e35211","DOI":"10.1371\/journal.pone.0035211","article-title":"Prediagnostic plasma 25-hydroxyvitamin D levels and risk of nonmelanoma skin cancer in women.","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"key":"R34-7-20211004","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1158\/1078-0432.CCR-05-1237","article-title":"Phase III study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.","volume":"11","author":"Schwartz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R35-7-20211004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/bjc.1998.434","article-title":"A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer.","volume":"78","author":"Gulliford","year":"1998","journal-title":"Br J Cancer"},{"key":"R36-7-20211004","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s10637-010-9492-5","article-title":"A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors.","volume":"29","author":"Jain","year":"2011","journal-title":"Invest New Drugs"},{"key":"R37-7-20211004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"R38-7-20211004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1192\/bjp.bp.111.106666","article-title":"Vitamin D deficiency and depression in adults: systematic review and meta-analysis.","volume":"202","author":"Anglin","year":"2013","journal-title":"Br J Psychiatry"},{"key":"R39-7-20211004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","article-title":"Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain.","volume":"29","author":"Eyles","year":"2005","journal-title":"J Chem Neuroanat"},{"key":"R40-7-20211004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2796.2008.02008.x","article-title":"Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial.","volume":"264","author":"Jorde","year":"2008","journal-title":"J Intern Med"},{"key":"R41-7-20211004","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.bp.110.087544","article-title":"Annual high-dose vitamin D3 and mental well being: randomised controlled trial.","volume":"198","author":"Sanders","year":"2011","journal-title":"Br J Psychiatry"},{"key":"R42-7-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwr482","article-title":"Vitamin D supplementation and depression in the womens health initiative calcium and vitamin D trial.","volume":"176","author":"Bertone-Johnson","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R44-7-20211004","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","article-title":"Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjogrens syndrome.","volume":"39","author":"Agmon-Levin","year":"2012","journal-title":"J Autoimmun"},{"key":"R45-7-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/bjc.2012.194","article-title":"The relationship between vitamin D and chemotherapy-induced toxicity - a pilot study.","volume":"107","author":"Kitchen","year":"2012","journal-title":"Br J Cancer"},{"key":"R47-7-20211004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"}],"container-title":["Current Opinion in Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01263393-201309000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:42:24Z","timestamp":1715794944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01263393-201309000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e3283640f74","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}